Xeris Biopharma Holdings, Inc. (XERS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $383.53M | +18.7% |
| 2024 | $323.06M | +0.1% |
| 2023 | $322.60M | -6.4% |
| 2022 | $344.52M | +13.2% |
| 2021 | $304.36M | +91.2% |
| 2020 | $159.15M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $383.53M | +18.7% |
| 2024 | $323.06M | +0.1% |
| 2023 | $322.60M | -6.4% |
| 2022 | $344.52M | +13.2% |
| 2021 | $304.36M | +91.2% |
| 2020 | $159.15M | — |